Neurotransmitters Amines Quaternary amines Acetylcholine (ACh) Monoamines Catecholamines Epinephrine (EPI) Norepinephrine (NE) Dopamine (DA) Indoleamines.

Slides:



Advertisements
Similar presentations
Neurobiology of Schizophrenia, Mood Disorders, and Anxiety Disorders Chapter 18 Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate.
Advertisements

Mood Disorders chapter six
Mood Disorders and Suicide Dr. Angela Whalen Kaplan University
Chapter 16 Depression. Two Major Categories of Mood Disorder Major depressive disorder (unipolar): Lengthy, uninterrupted periods of depressed mood. Manic.
1. If a stimulus shifts the potential inside a neuron from the resting potential to a more negative potential, the result is __________. A) hyperpolarization.
Mood Disorders and Suicide
Chapter 6 Mood Disorders and Suicide. An Overview of Mood Disorders Extremes in Normal Mood –Nature of depression –Nature of mania and hypomania Types.
Widely Found and Studied Neurotransmitters  Glutamate – has excitatory functions  4 Ascending activating systems are very important  Cholinergic System.
NEURAL TRANSMISSION Neurons Electrical and Chemical Transmission.
NANCY LONG SIEBER, PH.D. SEPT. 13, 2010 A bit about lupus and then Neuropathophysiology I.
Chapter 15 Psychological Disorders. Substance Abuse and Addictions Mental illness.
Mood Disorders Also known as affective disorders Depression, mania, or both Definition of depression Definition of mania Hypomania.
CHEM E-120 Harvard University Extension School Spring 2011 Hypothalamus-Pituitary-Adrenal Neuroendocrine System HPA Axis 2/16/111CHEM E-120.
Copyright © 2007 Wolters Kluwer Health | Lippincott Williams & Wilkins Neuroscience: Exploring the Brain, 3e Chapter 22: Mental Illness.
Neuropathophysiology Synaptic Transmission & Neurotransmitters September 24, 2012 Ashkan Afshin.
1 Mood Disorders Bi / CNS 150 Lecture 26 Monday December 1, 2014 Bruce Cohen Kandel Chap. 63:
Antidepressants and Treatment of Mood Disorders Anita S. Kablinger M.D. Associate Professor Departments of Psychiatry and Pharmacology.
Chapter Fifteen Alcoholism, Mood Disorders, and Schizophrenia.
Neurobiology of Schizophrenia, Mood Disorders, and Anxiety Disorders Chapter 18 Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate.
Unipolar Depression. Sad & helpless every day for weeks Loss of interests, energy, appetite Feel worthless Contemplate suicide Difficulty in concentrating.
Mood Disorders Lesson 25. Mood Disorders n Unipolar depression n Mania n Bipolar disorder n Seasonal Affective Disorder (SAD) ~
Mood Disorders Lesson 25. Mental Illness: Definition n Characteristically Controversial l *Disorder vs socially unacceptable n Deviations from normal.
Mood Disorders.
Mood Disorders and Suicide
 Gross Deviations in Mood  Depression: “The Low” –The “Common Cold” of Mental Illness –Major Depressive Episode is Most Common  Mania: “The High” –Abnormally.
Affective and Anxiety Disorders. What are affective disorders? Disorders of mood found throughout history unipolar or major depression bipolar or manic.
Mood Disorders. Major Depressive Disorder  Five or more symptoms present for two weeks or more:  Disturbed Mood  depressed mood  anhedonia (reduced.
Chapter 7 Mood Disorders and Suicide
Chapter 6 Mood Disorders and Suicide. An Overview of Mood Disorders Mood Disorders –Gross deviations in mood –Major depressive episodes –Manic and hypomanic.
Two principle types of affective disorder –Major depression Unipolar disorder –Bipolar disorder Sometimes referred to as manic-depressive disorder.
Neurotransmitters Neuropeptides Amines Amino acids Opioid peptides
The Biological Basis of Affective Disorders and Schizophrenia
Chapter 6 Mood Disorders
GABA and Glycine: recap Inhibitory neurotransmitters Synthesis and packaging into vesicles. Removal from synapse Date-rape drug: gamma-hydroxybutyrate.
Slide 1 Neuroscience: Exploring the Brain, 3rd Ed, Bear, Connors, and Paradiso Copyright © 2007 Lippincott Williams & Wilkins Bear: Neuroscience: Exploring.
Endocrine Glands.
Neurological Disorders. Psychological Disorders 10 million people suffer from depression.
Neurotransmitters Lecture 13.
Chapter Fifteen Alcoholism, Mood Disorders, and Schizophrenia.
Moods Disorders and Suicide
Mood Disorder Categories (DSM-IV) Depressive disorders –Major depressive disorder, clinical depression –Dysthymia –Depressive Disorder Not Otherwise Specified.
Chapter 16 Depression. Mood Disorders and Creativity.
Copyright ©2007 The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Mood Disorders ©
Neurotransmitters & Receptors Lecture 10. Ligands & Receptors n Ligand l Neurotransmitters (NT) & Drugs n Receptor proteins l Control ion channels n NT.
Bipolar Disorder. Hallmark of Bipolar Disorder Defined by manic symptoms – Elevated, expansive or irritable mood (or any combination of these moods) plus.
PSYCHOACTIVE DRUGS Drugs have revolutionized psychiatric treatment since the 1950's. Most psychoactive drugs act stereospecifically on receptors, enzymes,
Stress and Drugs of Abuse An Introduction. I. Drugs of Abuse and Addiction A. Reward, Reinforcement and Motivation 1. addiction: an overwhelming dependence.
Neurotransmitters Lesson 13. Neurotransmitters n Chemical messengers l Signal between cells n Released at axon terminal l By action potentials n Metabolism.
Mood Disorders Lesson 24.
Mood Disorders Unipolar Depression & Bipolar Disorder.
Neurotransmitters A. Criteria 1. must mimic presynaptic effects if administered exogenously 2. must be released during activity of presynaptic neuron 3.
Neurotransmitters: Monoamines
Unit 3 – Neurobiology and Communication
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Neurobiology 404 Depression, mood disorders Schizophrenia.
Dr Aseni Wickramatillake. What is a mood disorder? Mood: An individual’s personal state of emotions Affect : An individual’s appearance of mood Moods.
Pharmacology of central Neurotransmitters Prof. Yieldez.
Depression and Its Treatment Les Secrest, M.D.. Worldwide Depression accounts for a high level of disability and decreased functioning.
The Nervous System-Part II
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
Neurotransmitters Amines Quaternary amines Acetylcholine (ACh) Monoamines Catelcholamines Epinephrine (EPI) Norepinephrine (NE) Dopamine (DA) Indoleamines.
Neurotransmitters Amines Quaternary amines Acetylcholine (ACh) Monoamines Catecholamines Epinephrine (EPI) Norepinephrine (NE) Dopamine (DA) Indoleamines.
Neurotransmitters.
Neurotransmitters Neuropeptides Amines Amino acids Opioid peptides
Chemical Messengers Autocrine Paracrine Endocrine Pheromone Allomone
Pharmacology of central Neurotransmitters Prof. Yieldez Bassiouni
Introduction to depression and antidepressant agents
Chapter 12 Mood Disorders and Depression
Neuroscience: Exploring the Brain, 3e
Psychological Disorders
Presentation transcript:

Neurotransmitters Amines Quaternary amines Acetylcholine (ACh) Monoamines Catecholamines Epinephrine (EPI) Norepinephrine (NE) Dopamine (DA) Indoleamines Serotonin (5-HT) Melatonin Amino acids Gamma-aminobutyric acid (GABA) Glutamate (GLU) Glycine Histamine (HIST) Neuropeptides Opioid peptides Enkephalins (ENK) Endorphins (END) Peptide Hormones Oxytocin (Oxy) Substance P Cholecystokinin (CCK) Vasopressin (ADH) Neuropeptide Y (NPY) Brain-derived Neurotrophic factor Hypothalamic Releasing Hormones GnRH TRH CRH Lipids Anandamide Gases Nitric Oxide (NO)

5-Hydroxytryptamine (5-HT)

Features of a serotonergic neuron

Serotoninergic (5-HT) System

Serotonergic Receptors 5-HT 1A-F receptors CNS Blood Vessels 5-HT 2A-C receptors CNS PNS Blood Vessels GI Tract 5-HT 3 receptors CNS PNS GI Tract 5-HT 4 receptors CNS PNS GI Tract 5-HT 5A-B receptors CNS 5-HT 6 receptors CNS 5-HT 7 receptors CNS Blood Vessels GI Tract Iontotropic Metabotropic 5-HT 1B receptor

5-HT 1A and 5-HT 2A receptors operate through different signaling mechanisms

Serotonergic Drugs

Mood Disorders Unipolar Disorder (2 wks to 9 mos) Major Depressive Disorder, Single Episode (MDDSE) rare Major Depressive Disorder, Recurrent (MDDR) family history is common Dysthymic Disorder (DD) milder symptoms chronic occurrence (2-30yrs) Double Depression combination or MDDR and DD Bipolar Disorder (2 wks to 9 mos) Bipolar I Disorder Bipolar II Disorder (hypomania) Dysphoric Mania manic episodes with simultaneous depression Cyclothymic Disorder (mild bipolar)

Major Depressive Episode Characteristics Onset is in early to mid 20’s but not age specific Onset age has been dropping 16% of population experience MDD in their lifetime 2:1 women to men ratio 41% occurs just before or just after menstruation

Mood Disorder Genetics

Depression and Stress Hormones cortisol steroid hormone

HPA Axis Hypothalamus CRF/CRH Pituitary ACTH Adrenals Cortisol

Stress Diathesis Model Existing Correlations: Adult Depression : Elevated Cortisol levels Childhood Abuse : Adult Depression Stress Diathesis Model: Genetic Predisposition plus Early Abuse/Neglect leads to Adult Depression Animal Model shows: More CRF neurons Larger CRF neurons More sensitive CRF neurons Early abuse permanently alters the stress response increasing the risk of depression

Cortisol Abnormalities

Sleep Abnormalities

Monoamine Hypothesis Originated with observation of Reserpine action: Inhibits vesicular uptake Allowing MAO degradation Reduces levels of DA, NE, and 5-HT Induces depression-like symptoms MAOi suppresses depression-like symptoms

Serotonin Hypothesis Acute Effects: Transporters blocked Autoreceptors activated Cancelling effect Chronic Effects: Transporters blocked Autoreceptors down regulated Increased 5-HT in synapse

Serotonin Hypothesis Metabolite of 5-HT: 5-HIAA Increased levels found in people who committed suicide

5-HT Receptors Less sensitive Sensitivity restored with use of antidepressants 5 HT 2 Receptors Increased density Due to low 5-HT levels? Chronic use of antidepressants down regulated 5-HT 2 receptors Serotonin Hypothesis

Serotonin-Norepinephrine Hypothesis down-regulation of β- receptors with chronic antidepressant treatment. takes 7 to 21 days of treatment, a lag that parallels the onset of therapeutic response in depressed patients. Similar results occur with many different antidepressants. But not all antidepressants reduce β -receptors. There are anatomical and functional interactions between NE neurons originating in the locus coeruleus and the 5-HT neurons in the raphe nuclei. Each system is capable of modulating the other.

Glucocorticoid Hypothesis focuses on the stress-related neuroendocrine abnormalities of depression. Depressed patients have abnormally high CRF secretion. The hypothalamic CRF neurons are normally controlled by other areas: the amygdala stimulates and the hippocampus has inhibitory control. When stress is prolonged and intense, glucocorticoid levels remain high, hippocampal neurons are damaged and no longer respond. Damage includes decreased dendritic branches and spines in the PFC and hippocampus. Formation of new hippocampal cells is inhibited Cell loss in the hippocampus means reduced response to cortisol levels and loss of feedback inhibition of the HPA axis. Antidepressant drugs reduce levels of CRF and reverse loss of hippocampal dendrites in animal studies Cell loss in the hippocampus means reduced response to cortisol levels and loss of feedback inhibition of the HPA axis. Antidepressant drugs reduce levels of CRF and reverse loss of hippocampal dendrites in animal studies..

Neurotrophic Hypothesis Low BDNF (brain-derived neurotrophic factor) may be responsible for the loss of dendritic branches and spines in the hippocampus and PFC and for reduced neurogenesis in the hippocampus. Antidepressants may prevent decrease of BDNF Supporting evidence: Chronic stress reduces BDNF in the hippocampus in rats. Chronic but not acute antidepressant treatment increases BDNF in animals and humans. Antidepressants prevent stress- induced reduction in BDNF and neuronal atrophy.

Neurotrophic Hypothesis Early life stress can lead to epigenetic changes that enhance CRF expression in the amygdala and hypothalamus and decreased glucocorticoid receptors in the hippocampus. The gene for BDNF can be modified by chromatin remodeling (epigenetic changes) that affect levels of gene expression.

Depression: Treatment Medical Chemical Electroconvulsive Shock Therapy Psychotherapy Cognitive Behavioral Therapy Interpersonal Therapy

Chemical Treatment Tricyclic Antidepressants imipramine (Tofranil) prevents monoamine reuptake 64% respond well many side effects Monoamine Oxidase Inhibitors (MAOi) phenelzine (Nardil) blocks MAO enzyme which breaks down monoamines <64% respond well several lethal side effects Selective Serotonin Reuptake Inhibitors (SSRIs) fluoxetine (Prozac) blocks reuptake of serotonin minor side effects

Treatment Strategies

Cognitive Behavioral Therapy make patient examine thought process and recognize errors arbitrary interference overgeneralization try to correct cognitive errors concentrate on less depressive thoughts - be more realistic target negative cognitive schemes use journals to identify faulty thinking do hypothesis testing put fun back into the patients life increase exercise takes about sessions